Legend Biotech Corp ADR [LEGN] stock prices are up 12.10% to $54.37 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The LEGN shares have gain 17.43% over the last week, with a monthly amount glided 22.87%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Legend Biotech Corp ADR [NASDAQ: LEGN] stock has seen the most recent analyst activity on June 17, 2024, when Truist initiated its Buy rating and assigned the stock a price target of $88. Previously, H.C. Wainwright reaffirmed its Buy rating on May 24, 2024, and dropped its price target to $73. On May 23, 2024, Deutsche Bank initiated with a Buy rating and assigned a price target of $60 on the stock. Scotiabank upgraded its rating to a Sector Outperform but stick to its price target of $65 on April 17, 2024. Cantor Fitzgerald initiated its recommendation with a Overweight and recommended $82 as its price target on April 03, 2024. Raymond James started tracking with a Outperform rating for this stock on March 13, 2024, and assigned it a price target of $86. In a note dated December 19, 2023, Scotiabank initiated an Sector Perform rating.
The stock price of Legend Biotech Corp ADR [LEGN] has been fluctuating between $38.60 and $77.32 over the past year. Currently, Wall Street analysts expect the stock to reach $78.78 within the next 12 months. Legend Biotech Corp ADR [NASDAQ: LEGN] shares were valued at $54.37 at the most recent close of the market. An investor can expect a potential return of 44.9% based on the average LEGN price forecast.
Analyzing the LEGN fundamentals
The Legend Biotech Corp ADR [NASDAQ:LEGN] reported sales of 342.80M for trailing twelve months, representing a surge of 158.67%. Gross Profit Margin for this corporation currently stands at 0.49% with Operating Profit Margin at -1.15%, Pretax Profit Margin comes in at -1.37%, and Net Profit Margin reading is -1.36%. To continue investigating profitability, this company’s Return on Assets is posted at -0.26, Equity is -0.36 and Total Capital is -0.26. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.25.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 49.22 points at the first support level, and at 44.08 for the second support level. However, for the 1st resistance point, the stock is sitting at 58.51, and for the 2nd resistance point, it is at 62.65.
Ratios To Look Out For
It’s worth pointing out that Legend Biotech Corp ADR [NASDAQ:LEGN]’s Current Ratio is 5.66. In addition, the Quick Ratio stands at 5.57 and the Cash Ratio stands at 3.6. Considering the valuation of this stock, the price to sales ratio is 28.91, the price to book ratio is 8.51.
